https://www.taxtmi.com/caselaws?id=432283 The Tribunal upheld the CIT(A)'s decision in dismissing the Revenue's appeal entirely, while partially allowing the assessee's appeal and remanding specific issues for further consideration. The Revenue's challenges regarding computation of Section 80IB deduction, deduction eligibility for profits from Loan Licensee Manufacturers, and disallowance of certain expenses were rejected based on consistency with prior rulings favoring the assessee. The Tribunal directed reconsideration of weighted deduction for clinical trial expenses and disallowance under Section 14A, allowing the assessee's grounds partially. en-us Fri, 23 Dec 2022 00:00:00 +0530 Sat, 31 Dec 2022 13:00:00 +0530 TaxTMI RSS Generator https://www.taxtmi.com/caselaws?id=432283 The Tribunal upheld the CIT(A)'s decision in dismissing the Revenue's appeal entirely, while partially allowing the assessee's appeal and remanding specific issues for further consideration. The Revenue's challenges regarding computation of Section 80IB deduction, deduction eligibility for profits from Loan Licensee Manufacturers, and disallowance of certain expenses were rejected based on consistency with prior rulings favoring the assessee. The Tribunal directed reconsideration of weighted deduction for clinical trial expenses and disallowance under Section 14A, allowing the assessee's grounds partially. Case-Laws Income Tax Fri, 23 Dec 2022 00:00:00 +0530 https://www.taxtmi.com/caselaws?id=432283